Literature DB >> 21927818

Conservative versus surgical management of Pipkin type I fractures associated with posterior dislocation of the hip: a randomised controlled trial.

Sujit Kumar Tripathy, Ramesh Kumar Sen, Tarun Goyal.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21927818      PMCID： PMC3224604          DOI： 10.1007/s00264-011-1352-1

Source DB:  PubMed          Journal:  Int Orthop        ISSN： 0341-2695            Impact factor:   3.075


× No keyword cloud information.
  3 in total

Review 1.  Femoral head fractures: diagnosis, management, and complications.

Authors:  Ferhan A Asghar; Madhav A Karunakar
Journal:  Orthop Clin North Am       Date:  2004-10       Impact factor: 2.472

2.  Conservative versus surgical management of Pipkin type I fractures associated with posterior dislocation of the hip: a randomised controlled trial.

Authors:  Zhi-wen Chen; Bin Lin; Wen-liang Zhai; Zhi-min Guo; Zhou Liang; Jia-Peng Zheng; Ke-jian Lian; Zheng-qi Ding
Journal:  Int Orthop       Date:  2010-08-03       Impact factor: 3.075

3.  Femoral head injuries: Which treatment strategy can be recommended?

Authors:  Philipp Henle; Peter Kloen; Klaus A Siebenrock
Journal:  Injury       Date:  2007-04-02       Impact factor: 2.586
  3 in total
  3 in total

1.  Comparison of the modified Heuter approach and the Kocher-Langenbeck approach in the treatment of Pipkin type I and type II femoral head fractures.

Authors:  Shanxi Wang; Bohua Li; Jun Li; Zhengdong Zhang; Hai Yang; Lei Liu
Journal:  Int Orthop       Date:  2019-01-25       Impact factor: 3.075

2.  Clinical results of femoral head fracture-dislocation treated according to the Pipkin classification.

Authors:  Xiao Yu; Qing-Jiang Pang; Xian-Jun Chen
Journal:  Pak J Med Sci       Date:  2017 May-Jun       Impact factor: 1.088

3.  Early versus delayed hip reduction in the surgical treatment of femoral head fracture combined with posterior hip dislocation: a comparative study.

Authors:  Shanxi Wang; Bohua Li; Zhengdong Zhang; Xiaojun Yu; Qin Li; Lei Liu
Journal:  BMC Musculoskelet Disord       Date:  2021-12-20       Impact factor: 2.362
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.